I think they are economic evaluation and not clinical trial per-se and shows that even the European government don't really look at FDA if it's has received CE which has demonstrated safety and efficacy. I suspect this will be the same for most European telehealth and countries.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Builds European Market Presence
Ann: ResApp Builds European Market Presence, page-5
-
- There are more pages in this discussion • 259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online